Borregaard (BRG) Company presentation summary
Event summary combining transcript, slides, and related documents.
Company presentation summary
29 Apr, 2026Business model and strategy
Operates an advanced biorefinery model, converting wood into high-value biochemicals, biomaterials, and fine chemicals, with 94% raw material utilization and a diversified product portfolio of 800 products across global markets.
Focuses on specialisation in global niche markets with high barriers to entry, leveraging application knowledge, innovation, and proximity to customers.
Strategic priorities include increased specialisation, value growth, targeted investments, and leveraging sustainability and regulatory trends as value drivers.
Maintains a market-driven organization with dedicated sales teams and a strong presence in Europe, Americas, and Asia.
Sustainability and innovation
Integrates sustainability throughout the value chain, using certified renewable raw materials and targeting significant CO2 reductions (42% by 2030, net-zero by 2050).
Recognized as a global leader in climate action, with top ratings from CDP and EcoVadis.
Invests in bio-based start-ups and innovation, with NOK 222 million allocated to R&D in 2025 and an innovation rate of 14%.
Transition plan includes energy efficiency, renewable energy, and process optimization to meet science-based targets.
BioSolutions segment
Largest global supplier of lignin-based biopolymers and only producer of wood-based vanillin, serving diverse applications in construction, agriculture, batteries, and personal care.
Sales revenues in BioSolutions have trebled since 2012, driven by specialisation and portfolio optimization.
Sustainability and regulatory trends drive new business, with opportunities in Asia, agriculture, electrification, and animal feed.
New green technologies target high-end markets such as home care and coatings, replacing fossil-based polymers.
Latest events from Borregaard
- EBITDA fell 16% year-over-year as cost inflation and weaker BioSolutions weighed on results.BRG
Q1 202629 Apr 2026 - Specialisation, innovation, and sustainability drive growth and strong financial performance.BRG
Company presentation29 Apr 2026 - AGM approved a 12% dividend increase, board renewal, and strong financial and sustainability plans.BRG
AGM 202624 Apr 2026 - BioMaterials and BioSolutions volumes to grow in 2026, but pricing and cost risks persist.BRG
Pre-close call19 Mar 2026 - Record EBITDA, strong cash flow, higher dividend, and start-up impairments define the period.BRG
Q4 20254 Feb 2026 - BioSolutions strength offset weaker BioMaterials; outlook cautious amid rising costs.BRG
Q2 20243 Feb 2026 - Specialization, innovation, and sustainability drive robust growth and disciplined investment.BRG
CMD 202420 Jan 2026 - Q3 revenue and EBITDA rose on volume growth and expansion, but cost and market risks remain.BRG
Q3 202417 Jan 2026 - Strong growth, sustainability, and expansion drive value in advanced biorefinery markets.BRG
SEB Nordic Seminar presentation16 Jan 2026